BUDA, ALESSANDRO ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 7.914
AS - Asia 3.190
EU - Europa 2.913
SA - Sud America 485
Continente sconosciuto - Info sul continente non disponibili 318
AF - Africa 88
OC - Oceania 11
Totale 14.919
Nazione #
US - Stati Uniti d'America 7.488
SG - Singapore 1.098
CN - Cina 731
IT - Italia 711
HK - Hong Kong 424
DE - Germania 407
RU - Federazione Russa 400
VN - Vietnam 400
BR - Brasile 356
SE - Svezia 339
CA - Canada 332
IE - Irlanda 235
GB - Regno Unito 194
UA - Ucraina 156
IN - India 149
FR - Francia 142
BD - Bangladesh 71
FI - Finlandia 70
TR - Turchia 52
MX - Messico 47
AR - Argentina 42
DK - Danimarca 41
ES - Italia 39
IQ - Iraq 39
JP - Giappone 39
AT - Austria 35
PL - Polonia 27
ZA - Sudafrica 27
BE - Belgio 25
CO - Colombia 24
NL - Olanda 24
SA - Arabia Saudita 23
PH - Filippine 22
PK - Pakistan 19
EC - Ecuador 18
KR - Corea 18
CZ - Repubblica Ceca 16
ID - Indonesia 16
MA - Marocco 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
UZ - Uzbekistan 11
CH - Svizzera 10
EG - Egitto 10
EU - Europa 10
MY - Malesia 10
PY - Paraguay 10
AU - Australia 9
IR - Iran 9
KE - Kenya 9
PE - Perù 8
PT - Portogallo 8
JM - Giamaica 7
RO - Romania 7
TN - Tunisia 7
CR - Costa Rica 6
DZ - Algeria 6
EE - Estonia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AZ - Azerbaigian 5
BG - Bulgaria 5
CL - Cile 5
DO - Repubblica Dominicana 5
GT - Guatemala 5
HN - Honduras 5
LB - Libano 5
RS - Serbia 5
TH - Thailandia 5
UY - Uruguay 5
BO - Bolivia 4
KZ - Kazakistan 4
NI - Nicaragua 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
AL - Albania 3
ET - Etiopia 3
IL - Israele 3
JO - Giordania 3
KG - Kirghizistan 3
PR - Porto Rico 3
SC - Seychelles 3
SN - Senegal 3
BZ - Belize 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MD - Moldavia 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
Totale 14.599
Città #
Ann Arbor 1.191
Ashburn 853
Singapore 651
San Jose 410
Fairfield 387
Hong Kong 375
Houston 346
Chandler 329
Woodbridge 322
Wilmington 268
Toronto 236
Dublin 228
Frankfurt am Main 187
Milan 181
Dearborn 169
New York 169
Seattle 160
Jacksonville 143
Cambridge 138
Ho Chi Minh City 130
Council Bluffs 123
Los Angeles 122
Beijing 108
Santa Clara 108
The Dalles 91
Princeton 90
Dallas 85
Hanoi 83
Chicago 77
Shanghai 69
Nanjing 68
Boardman 67
Lissone 60
Buffalo 54
Altamura 53
Munich 50
São Paulo 48
Lauterbourg 45
Lawrence 43
Fremont 42
Rome 35
San Diego 35
Orem 32
Hefei 31
Vienna 31
Tokyo 30
London 29
Nanchang 29
Helsinki 28
Montreal 28
Columbus 27
Brussels 25
Guangzhou 25
Chennai 24
Lachine 24
Atlanta 23
Moscow 23
Da Nang 22
Denver 22
Phoenix 21
Falls Church 20
Brooklyn 19
Johannesburg 19
Ottawa 18
Pune 18
Warsaw 17
Baghdad 16
Turku 16
Washington 16
Amsterdam 14
Hangzhou 14
Boston 13
Jinan 13
Kunming 13
Monza 13
Nuremberg 13
Poplar 13
Rio de Janeiro 13
Seoul 13
Shenyang 13
Dhaka 12
Haiphong 12
Hebei 12
Salt Lake City 12
Andover 11
Biên Hòa 11
Brno 11
Düsseldorf 11
Manchester 11
Mexico City 11
Newark 11
Paris 11
Bologna 10
Brasília 10
San Francisco 10
Secaucus 10
Tashkent 10
Curitiba 9
Jeddah 9
Medellín 9
Totale 9.420
Nome #
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 562
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 506
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 480
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 475
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 414
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 408
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 399
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 396
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 390
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 387
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 387
Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison 381
Sentinel node biopsy in endometrial cancer: an update 370
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 370
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 361
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 351
Effects of Peritoneal Ropivacaine Nebulization for Pain Control After Laparoscopic Gynecologic Surgery 347
Optimizing strategies for sentinel lymph node mapping in early-stage cervical and endometrial cancer: Comparison of real-time fluorescence with indocyanine green and methylene blue 337
The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study 336
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancyc 335
Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: Our experience and literature review 333
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 333
Sentinel Lymph Node Mapping With Near-Infrared Fluorescent Imaging Using Indocyanine Green: A New Tool for Laparoscopic Platform in Patients With Endometrial and Cervical Cancer 330
Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy 322
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 320
Near-Infrared Sentinel Lymph Node Mapping With Indocyanine Green Using the VITOM II ICG Exoscope for Open Surgery for Gynecologic Malignancies 316
Long-term clinical benefits of neoadjuvant chemotherapy in women with locally advanced cervical cancer: Validity of pathological response as surrogate endpoint of survival 310
Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON3 randomised trial 296
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 290
Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors 289
Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm) 281
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 277
Primary insular carcinoid of the ovary with carcinoid heart disease: Unfavourable outcome of a case 273
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 268
Sentinel lymph node detection in endometrial cancer: hysteroscopic peritumoral versus cervical injection 266
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma 264
Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience 253
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 251
Endometriosis-related spontaneous hemoperitoneum in pregnancy: A case series 221
Lymphadenectomy in uterine low-grade endometrial stromal sarcoma: an analysis of 19 cases and a literature review 214
Eviscerazione pelvica 213
Prognostic factors in patients with vulvar cancer: the VULCAN study 192
Cervical injection for sentinel lymph nodes detection in endometrial cancers is controversial: response to comments 186
KRas-LCS6 polymorphism does not impact on outcomes in ovarian cancer 180
Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study 167
Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer 165
Qualità di vita dopo trapianto di fegato per epatite fulminante 117
Totale 14.919
Categoria #
all - tutte 47.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022534 0 0 0 69 58 71 44 52 31 67 60 82
2022/20231.180 102 387 101 127 66 195 11 58 77 10 34 12
2023/2024803 21 22 44 45 100 219 200 27 28 3 3 91
2024/20251.727 94 181 108 82 128 81 100 74 158 305 164 252
2025/20265.063 603 231 376 562 560 269 778 211 425 397 361 290
2026/2027982 114 218 472 178 0 0 0 0 0 0 0 0
Totale 14.919